Phase III results for the Novel Neurokinin-1 (NK-1) Receptor Antagonist, Casopitant: Single Oral Dosing Regimen for Chemotherapy-induced Nausea and Vomiting (CINV) in Patients (Pts) Receiving Multiple Cycles of Highly Emetogenic Chemotherapy (HEC)

Jørn Herrstedt, J. Rolski, M. Guckert, I. Camlett, M. W. Russo, J. Strausz, Z. Aziz

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning

OriginalsprogEngelsk
Publikationsdato2008
StatusUdgivet - 2008
BegivenhedAmerican Society of Clinical Oncology - Chicago, USA
Varighed: 30. maj 20083. jun. 2008
Konferencens nummer: 44

Konference

KonferenceAmerican Society of Clinical Oncology
Nummer44
LandUSA
ByChicago
Periode30/05/200803/06/2008

Citer dette

Herrstedt, J., Rolski, J., Guckert, M., Camlett, I., Russo, M. W., Strausz, J., & Aziz, Z. (2008). Phase III results for the Novel Neurokinin-1 (NK-1) Receptor Antagonist, Casopitant: Single Oral Dosing Regimen for Chemotherapy-induced Nausea and Vomiting (CINV) in Patients (Pts) Receiving Multiple Cycles of Highly Emetogenic Chemotherapy (HEC). Poster session præsenteret på American Society of Clinical Oncology, Chicago, USA.
Herrstedt, Jørn ; Rolski, J. ; Guckert, M. ; Camlett, I. ; Russo, M. W. ; Strausz, J. ; Aziz, Z. / Phase III results for the Novel Neurokinin-1 (NK-1) Receptor Antagonist, Casopitant: Single Oral Dosing Regimen for Chemotherapy-induced Nausea and Vomiting (CINV) in Patients (Pts) Receiving Multiple Cycles of Highly Emetogenic Chemotherapy (HEC). Poster session præsenteret på American Society of Clinical Oncology, Chicago, USA.
@conference{e29380c0a02311dd9b31000ea68e967b,
title = "Phase III results for the Novel Neurokinin-1 (NK-1) Receptor Antagonist, Casopitant: Single Oral Dosing Regimen for Chemotherapy-induced Nausea and Vomiting (CINV) in Patients (Pts) Receiving Multiple Cycles of Highly Emetogenic Chemotherapy (HEC)",
author = "J{\o}rn Herrstedt and J. Rolski and M. Guckert and I. Camlett and Russo, {M. W.} and J. Strausz and Z. Aziz",
year = "2008",
language = "English",
note = "null ; Conference date: 30-05-2008 Through 03-06-2008",

}

Herrstedt, J, Rolski, J, Guckert, M, Camlett, I, Russo, MW, Strausz, J & Aziz, Z 2008, 'Phase III results for the Novel Neurokinin-1 (NK-1) Receptor Antagonist, Casopitant: Single Oral Dosing Regimen for Chemotherapy-induced Nausea and Vomiting (CINV) in Patients (Pts) Receiving Multiple Cycles of Highly Emetogenic Chemotherapy (HEC)', American Society of Clinical Oncology, Chicago, USA, 30/05/2008 - 03/06/2008.

Phase III results for the Novel Neurokinin-1 (NK-1) Receptor Antagonist, Casopitant: Single Oral Dosing Regimen for Chemotherapy-induced Nausea and Vomiting (CINV) in Patients (Pts) Receiving Multiple Cycles of Highly Emetogenic Chemotherapy (HEC). / Herrstedt, Jørn; Rolski, J.; Guckert, M.; Camlett, I.; Russo, M. W.; Strausz, J.; Aziz, Z.

2008. Poster session præsenteret på American Society of Clinical Oncology, Chicago, USA.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning

TY - CONF

T1 - Phase III results for the Novel Neurokinin-1 (NK-1) Receptor Antagonist, Casopitant: Single Oral Dosing Regimen for Chemotherapy-induced Nausea and Vomiting (CINV) in Patients (Pts) Receiving Multiple Cycles of Highly Emetogenic Chemotherapy (HEC)

AU - Herrstedt, Jørn

AU - Rolski, J.

AU - Guckert, M.

AU - Camlett, I.

AU - Russo, M. W.

AU - Strausz, J.

AU - Aziz, Z.

PY - 2008

Y1 - 2008

M3 - Poster

ER -